Willow bark

Willow bark is a botanical remedy with a history of use spanning millennia for the treatment of pain, fever, and inflammation. Derived from the bark of several species of the willow tree (Salix genus), most notably white willow (Salix alba), its medicinal properties were documented by ancient civilizations in Sumer, Egypt, and Greece, where the physician Hippocrates recommended it for alleviating pain and fever in the 5th century BCE. The therapeutic effects of willow bark are primarily attributed to its active compound, salicin.

Upon ingestion, salicin is metabolized in the body into salicylic acid, a chemical that inhibits the production of prostaglandins—hormone-like substances involved in inflammation, pain, and fever. This mechanism of action is similar to that of aspirin (acetylsalicylic acid), which is a synthetic derivative of salicylic acid. However, the effects of willow bark are generally considered to be slower to onset and milder than those of aspirin. This is partly because the salicin must be converted to its active form and partly because the doses of salicin in typical herbal preparations are lower. Some evidence suggests that other compounds in the bark, such as polyphenols and flavonoids, may contribute to its therapeutic effects and potentially reduce gastrointestinal side effects compared to aspirin.

Willow bark holds a significant place in the history of pharmacology as a quintessential example of a natural product leading to the development of a modern synthetic drug. The isolation of salicin in the 1820s and its subsequent synthesis into salicylic acid and then acetylsalicylic acid by chemists at the Bayer company in the late 19th century marked a pivotal moment in medicine, launching the era of synthetic pharmaceuticals. It serves as a bridge between traditional herbalism and modern evidence-based medicine, demonstrating the value of investigating the chemical basis of folk remedies.